| 词条 | Harvard Bioscience |
| 释义 |
}}{{Infobox company | name = Harvard Bioscience, Inc. | logo = Harvard_Bioscience_logo.jpg | type = Public | traded_as = {{NASDAQ|HBIO}} | foundation = 1901 | location = 84 October Hill Road Holliston, MA 01746, United States | industry = Life Science | products = | revenue = $104.521 million[1] | homepage = http://www.harvardbioscience.com/ }} Harvard Bioscience, Inc. is a global developer, manufacturer and marketer of a broad range of specialized products, primarily apparatus and scientific instruments used to advance life science research. Headquartered in Holliston, Massachusetts, United States, the company has 20 wholly owned subsidiaries. Brands include: AHN Biotechnologie, Biochrom, BioDrop, BTX, CMA, Coulbourn Instruments, Denville Scientific, Harvard Apparatus, HEKA, Hoefer, Hugo Sachs Elektronik, Multichannel Systems, Panlab, Scie-Plas, and Warner Instruments.[2] HistoryHarvard Bioscience was founded in 1901. Frustrated by the poor quality of equipment then available, Dr. William T. Porter began manufacturing his own high quality physiology teaching equipment in the basement of the Harvard Medical School. Dr. Porter went on to found the American Journal of Physiology and became one of the leading physiologists of his day. His equipment gained an enviable reputation for quality and reliability and began to be known simply as the Harvard Apparatus. In the early 1980s, the company started using the name Harvard Bioscience; the name was not officially changed to Harvard Bioscience, Inc. until 2000. The company completed their initial public offering in December 2000. The names Harvard Apparatus and Harvard Bioscience are used pursuant to a license agreement between Harvard University and Harvard Bioscience, Inc.[3] ProductsHarvard Bioscience offers a wide array of products for life science research. Their product portfolio is broken into five market segments: Fluidics, Laboratory Equipment & Supplies, Molecular Analysis, Cell Analysis, and Physiology.[4] FinanceThe revenue of the company grew from $11.5 million in 1997 to $108.2 million in 2010, a CAGR of 19%.[5] The revenue of the company for fy 2013 reached 105.57 million with the profit margin of 0.12% and operation margin of -1.01%.[6] On November 13, 2013, Harvard Bioscience Inc. announced its allocation of tax basis for spin-off of Harvard Apparatus Regenerative Technology.[7] References
1. ^HARVARD BIOSCIENCE, INC. • 2016 ANNUAL REPORT 2. ^{{cite web |url= https://finance.yahoo.com/q/pr?s=HBIO+Profile|title= Company Profile}} 3. ^{{cite web |url= http://www.harvardbioscience.com/about-us/history/|title= Company History}} 4. ^{{cite web |url= http://www.harvardbioscience.com/our-technologies/overview/|title= Our Technologies}} 5. ^{{cite web |url= http://www.harvardbioscience.com/overview.cfm?subsection=mission|title= Company Profile of Revenue Results}} 6. ^{{cite web |url= https://finance.yahoo.com/q/ks?s=HBIO+Key+Statistics|title= Company Financial Results}} 7. ^{{cite news |url= https://www.wsj.com/article/PR-CO-20131113-910801.html|title=Wall Street Journal News | work=The Wall Street Journal | date=November 13, 2013}} 6 : Life science companies based in Massachusetts|Technology companies based in the Boston area|Companies based in Middlesex County, Massachusetts|Holliston, Massachusetts|Technology companies established in 1901|1901 establishments in Massachusetts |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。